EQS-News: technotrans SE / Schlagwort(e): Sonstiges Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag 21.05.2024 / 13:57 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag Großvolumenauftrag im hohen einstelligen Millionen-Euro-Bereich Serienfertigung von Batterie-Thermomanagement-Systemen (BTMS) für mehrere E-Bus-Serien Wachstumsbeschleuniger im technotrans-Fokusmarkt Energy Management und Meilenstein im Segment Straßenfahrzeuge Sassen...
EQS-News: technotrans SE / Key word(s): Miscellaneous Battery cooling systems for new e-buses: technotrans secures major order 21.05.2024 / 13:57 CET/CEST The issuer is solely responsible for the content of this announcement. Battery cooling systems for new e-buses: technotrans secures major order Large-volume order in the high single-digit million euro range Series production of battery thermal management systems (BTMS) for several e-bus series Growth accelerator in technotrans' focus market Energy Management and milestone in the road vehicles segment Sassenberg, 21 M...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)Alvotech will be responsible for development and manufacture of the product HYDERABAD, INDIA & REYKJAVIK, ICELAND — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Red...
Alvotech gengur til samstarfs við Dr. Reddy‘s um markaðssetningu AVT03, fyrirhugaðrar hliðstæðu við Prolia og Xgeva, í Bandaríkjunum og Evrópu Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hefði gert samstarfssamning við Dr. Reddy’s Laboratories SA, dótturfyrirtæki Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) um sölu- og markaðssetningu AVT03, fyrirhugaðrar líftæknilyfjahliðstæðu Alvotech við Prolia og Xgeva, sem bæði innnihalda denosumab. Dr. Reddy er alþjóðlegt lyfjafyrirtæki með höfuðstöðvar á Indlandi en starfsemi um allan heim. Prolia og Xgeva eru líftæknilyf við ýmsum þr...
KANZHUN LIMITED Announces Board Changes BEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Shangyu Gao has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on May 21, 2024. In addition, with effect from May 21, 2024, Ms. Mengyuan Dong has been appointed as an independent non-executive director of the Company, the chairman of the audit committee, a member...
Alarum Announces Q1 2024 Results First quarter record revenues of $8.4 Million, up 47% year over year; IFRS gross margin climbed to 78% compared to 66% for the first quarter of last year IFRS net profit was $1.4 million while non-IFRS net profit surged to $2.8 million; Earnings per American Depository Share (EPS) of $0.23 and $0.45, respectively Adjusted EBITDA reached a record of $3.2 million Subsidiary NetNut’s revenues in the first quarter jumped 139% year over year; Net Retention Rate (“NRR”) increased to 1.66 TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- (N...
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip New Product Provides Engineers with Greater Flexibility in Designing for Higher Power Output in EV Chargers MANCHESTER, N.H., May 21, 2024 (GLOBE NEWSWIRE) -- (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the launch of the third product in its High Voltage Power-Thru™ portfolio. Allegro’s two-chip isolated gate-driver IC solutions work together with external transformers to provide the freedom to design and...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product HYDERABAD, India and REYKJAVIK, Iceland, May 21, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines fo...
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA. Event: TD Cowen’s 5th Annual Oncology Innovation SummitDate: Tuesday, May 28, 2024Time: 8:30 AM EDTLocation: Virtual The presentation will be webcast live and available for replay under “Events & Presentations” in the Investors section of the Co...
Pyxis Tankers Announces Financial Results for the Three Months Ended March 31, 2024 Maroussi, Greece, May 21, 2024 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, today announced unaudited results for the three months ended March 31, 2024. SummaryFor the three months ended March 31, 2024, our Revenues, net were $11.8 million. For the same period, our time charter equivalent (“TCE”) revenues were $10.2 million, an increase of $0.9 million, or 10.2%, over the comparable period in 2023. Our net income att...
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme Company Announcement No.28/2024 Copenhagen, 21 May 2024 Transactions in connection with share buy-back programme On 10 November 2023, Scandinavian Tobacco Group A/S announced that a share buy-back programme of an aggregated value of up to DKK 850 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. Part of the programme will be conducted in accordance with Regulation No. 596/2014 of the Europe...
Laurence de Moerlooze fratræder som EVP og Chief Medical Officer i Bavarian Nordic KØBENHAVN, Danmark, 21. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Laurence de Moerlooze har valgt at fratræde sin stilling som Executive Vice President og Chief Medical Officer i selskabet for at søge nye udfordringer. Hun fortsætter sit virke i Bavarian Nordic indtil udgangen af maj 2024. Selskabet vil iværksætte en søgning med henblik på ansættelse af en ny Chief Medical Officer. Paul Chaplin, administrerende direktør i Bavarian Nordic, udtaler: “På vegne af alle i Bavarian Nordic v...
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH Topline data now projected in early Q4 2024 Rohit Loomba, MD, MHSc to serve as Principal Investigator SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it has completed enrollment in the ALG-055009 Phase 2a HERALD study for metabolic dysfu...
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that Laurence de Moerlooze will leave her position as Executive Vice President and Chief Medical Officer in the Company to pursue new opportunities. She will continue to support Bavarian Nordic until the end of May 2024. The Company will initiate a search process to identify the next Chief Medical Officer. Paul Chaplin, President & CEO of Bavarian Nordic, said: “On behalf of everyone at Bavarian Nordic, I want to express my ...
Tempest to Participate in Upcoming Investor Conferences BRISBANE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that management will participate in the following upcoming investor conferences: TD Cowen's 5th Annual Oncology Innovation Summit – Fireside chat on Wednesday, May 29, 2024 at 2:00 p.m. ET Jefferies Global Healthcare Conference – Presentation on Wednesday, June 5, 2024 at 4:00 p.m. ET To access the l...
Auto Insurance Shopping Reaches New High in Q1 2024 TransUnion report finds U.S. consumers in the West and Midwest states drove auto and home insurance shopping in first quarter of 2024 CHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- The number of U.S. consumers who shopped for auto insurance in Q1 2024 increased by 6% YoY, compared to Q1 2023. This represents a five-year Q1 high and a continuation of strong growth in shopping observed in Q4 2023, according to new research from TransUnion (NYSE: TRU). This trend bolsters hopes that the personal lines insurance industry will move toward profi...
BASF Corporation enters class settlement with U.S. public water systems FLORHAM PARK, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- On May 20, 2024, BASF Corporation (“BASF”), the North American affiliate of BASF SE, agreed to a settlement with a nationwide class of public water systems that detected PFAS in their drinking water sources, which they allege to be associated with the use of Aqueous Film Forming Foam (“AFFF”) products. Some of the AFFF products at issue in the litigation were made using a surfactant produced by Ciba Specialty Chemicals (“Ciba”), which BASF acquired in 2009. In 2003,...
Asia Pacific Wire & Cable Corporation Limited to Host 2024 Annual Shareholders Meeting on July 15, 2024 TAIPEI, Taiwan, May 21, 2024 (GLOBE NEWSWIRE) -- Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) (the "Company"), a leading manufacturer of wire and cable products for the telecommunications and electric-power industries in the Asia-Pacific region, today announced that the Company will host its 2024 Annual General Meeting (the "Meeting") for shareholders at the office of Pacific Holdings Group located at 2901 Dallas Parkway, Suite 360, Plano, Texas 75093 on Monday, July 15,...
SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion • The SSi Mantra has surpassed the 100 surgery milestone for robotic cardiac surgery• SS Innovations maintains the world's only comprehensive robotic cardiac surgery program• SSi Mantra used in more than 1000 procedures globally• Company anticipates FDA approval in early 2025 FORT LAUDERDALE, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic te...
Axalta Announces Partnership with Solera, a Global Leader in Vehicle Lifecycle Management This partnership reinforces Axalta’s commitment to sustainability. PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Axalta (NYSE: AXTA), a leading global coatings company, today announced a partnership with Solera, a global leader in vehicle lifecycle management. Through this partnership, Axalta’s conventional and Fast Cure Low Energy (FCLE) refinish paint systems will be integrated into Solera’s Sustainable Estimatics platform, enabling Axalta customers to estimate their CO2 emissions per repair, wh...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.